October 20, 2017

 

Beth Schelle

 

Site Management Coordinator

Morton Plant Mease Health Care Inc.

455 Pinellas Street, Suite 212B

Clearwater, FL  33756

 

Reference No. 17-0063

 

Dear Ms. Schelle:

 

This letter is in response to your June 8, 2017, email requesting clarification of the Hazardous Materials Regulations (HMR; 49 CFR Parts 171-180) applicable to Category B infectious substances.  You ask if interpretation letter (Reference No. 09-0011) and the training requirements it describes for transporting Category B infectious substances in accordance with § 173.199 remain valid.

 

The answer is yes, interpretation letter (Reference No. 09-0011) remains valid.  Further, based on a cursory review of the training module you provided, it is the opinion of this Office that the content sufficiently covers the provisions in § 173.199.  Employees who are trained in and familiar with the requirements of § 173.199 are excepted from all other training requirements of the HMR when Category B infectious substances are offered for transportation or transported in commerce under the provisions of § 173.199.  Please note, this letter does not act as certification of your training module nor does this Office certify training required by § 173.199(e).

 

I hope this information is helpful.  Please contact us if we can be of further assistance.

 

Sincerely,

 

 

 

Dirk Der Kinderen

Chief, Standards Development Branch

Standards and Rulemaking Division

 

173.199,